A carregar...

Intratumoral immunotherapy for early-stage solid tumors

The unprecedented benefits of immunotherapy in advanced malignancies have resulted in increased interests in exploiting immune stimulatory agents in earlier stage solid tumors in the neoadjuvant setting. However, systemic delivery of immunotherapies may cause severe immune-related side-effects and h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Hong, Wan Xing, Haebe, Sarah, Lee, Andrew S., Westphalen, C. Benedikt, Norton, Jeffrey A., Jiang, Wen, Levy, Ronald
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7439755/
https://ncbi.nlm.nih.gov/pubmed/32071116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3642
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!